Walleye Capital
EVH icon

Walleye Capital’s Evolent Health EVH Stock Holding History

Walleye Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.92M Buy
1,122,301
+276,514
+33% +$1.23M ﹤0.01% 2149
2026
Q2 		$4.58M Buy
845,787
+709,839
+522% +$2.72M 0.02% 880
2026
Q1 		$310K Sell
135,948
-2,784
-2% -$8.83K ﹤0.01% 3040
2025
Q4 		$555K Sell
138,732
-515,729
-79% -$2.87M ﹤0.01% 2895
2025
Q3 		$5.54M Buy
654,461
+6,700
+1% +$65K 0.02% 871
2025
Q2 		$7.29M Buy
647,761
+595,458
+1,138% +$5.47M 0.03% 660
2025
Q1 		$495K Buy
52,303
+48,689
+1,347% +$492K ﹤0.01% 2570
2024
Q4 		$40.7K Buy
3,614
+678
+23% +$11.9K ﹤0.01% 4406
2024
Q3 		$83K Sell
2,936
-5,512
-65% -$142K ﹤0.01% 4472
2024
Q2 		$162K Buy
+8,448
New +$216K ﹤0.01% 4448
2021
Q4 		– Sell
-27,662
Closed -$858K – 2163
2021
Q3 		$858K Buy
+27,662
New +$664K 0.02% 535
2019
Q4 		– Sell
-49,368
Closed -$355K – 1921
2019
Q3 		$355K Buy
49,368
+20,597
+72% +$148K 0.02% 900
2019
Q2 		$229K Buy
+28,771
New +$341K 0.03% 891

Other funds holding EVH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Rubicon Founders
Rubicon Founders Nashville, Tennessee $147M AUM 17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Rock Point Advisors
Rock Point Advisors Burlington, Vermont $402M AUM 17.12% 1-Year Est. Return

Walleye Capital's EVH Position: Q3 2026 in Review

Walleye Capital increased its Evolent Health (EVH) stake by 33% in Q3 2026, buying an estimated $1.23M and bringing the position to 1,122,301 shares worth $3.92M. The position accounts for ﹤0.01% of the portfolio, ranked #2149.

Walleye Capital first reported a position in EVH in Q2 2019 and has held it in 13 quarters since. The position peaked at $7.29M in Q2 2025. 129 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Walleye Capital held 1,122,301 shares of Evolent Health worth $3.92M as of Q3 2026.
  • Walleye Capital bought 276,514 Evolent Health shares in Q3 2026, an estimated $1.23M.
  • Evolent Health made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2149 holding.
  • Walleye Capital first reported a position in Evolent Health in Q2 2019 and has held it in 13 quarters since.
  • Walleye Capital's Evolent Health position peaked at $7.29M in Q2 2025.
  • 129 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.